000 | 01793 a2200541 4500 | ||
---|---|---|---|
005 | 20250513061040.0 | ||
264 | 0 | _c19941014 | |
008 | 199410s 0 0 eng d | ||
022 | _a0105-4538 | ||
024 | 7 |
_a10.1111/j.1398-9995.1994.tb02273.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSabbah, A | |
245 | 0 | 0 |
_aA double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. _h[electronic resource] |
260 |
_bAllergy _cMay 1994 |
||
300 |
_a309-13 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Sublingual |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAerosols |
650 | 0 | 4 |
_aBetamethasone _xtherapeutic use |
650 | 0 | 4 |
_aChlorpheniramine _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aConjunctivitis, Allergic _xtherapy |
650 | 0 | 4 |
_aCromolyn Sodium _xtherapeutic use |
650 | 0 | 4 | _aDesensitization, Immunologic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOphthalmic Solutions |
650 | 0 | 4 |
_aPlant Extracts _xtherapeutic use |
650 | 0 | 4 | _aPoaceae |
650 | 0 | 4 | _aPollen |
650 | 0 | 4 |
_aRhinitis, Allergic, Seasonal _xtherapy |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aTablets |
650 | 0 | 4 |
_aTerfenadine _xtherapeutic use |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHassoun, S | |
700 | 1 | _aLe Sellin, J | |
700 | 1 | _aAndré, C | |
700 | 1 | _aSicard, H | |
773 | 0 |
_tAllergy _gvol. 49 _gno. 5 _gp. 309-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1398-9995.1994.tb02273.x _zAvailable from publisher's website |
999 |
_c8091749 _d8091749 |